Car t-cell therapy for multiple myeloma in India. Defeating Cancer With CAR T Cell Therapy In India Find hope and healing with CAR T Cell Therapy in India. Get in touch, and we will connect you with the top hospitals in India for CAR T-Cell therapy. Companies like Immunoact, Cellogen and Immuneel are making CAR T cell therapy in India. India has paid a lot of attention to CAR T-cell treatment, which is a new kind of immunotherapy. CAR T-Cell Therapy In India – Current Status February, 2024: In October 2023, the Central Drugs Standard Control Organization CDSCO), which is India’s equivalent of the US Food and Drug Administration, granted approval to NexCAR19, making it the first CAR-T cell therapy to be licensed in India. The license was granted based on the findings from two limited-scale clinical trials carried out in India involving a total of 64 individuals diagnosed with advanced lymphoma or leukemia.
Home grown CAR T-Cell therapy is developing at a very rapid pace in India. Immuneel is working hard to advance its pipeline. Dr. Dr.